Although loss of maspin expression was also frequently occurred in advanced and chemo-refractory cancers [22, 28, 33], doxorubicin resistance led by overexpression of maspin via inducing collagen-enriched microenvironment was observed in breast and ovarian cancer cells [34], revealing the opposing functions of maspin in different cancer types. This evidence concerns the gene SERPINB5 and ovarian cancer.